---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292419508.md"
description: "Duan Yongping increased his stake in POP MART to 7.65%; China Life plans to invest nearly 5 billion to establish a semiconductor fund; CHINAHONGQIAO expects a 39% increase in net profit for the first half of the year; ZHONGLIANG HLDG's contract sales for the first half of the year are approximately 3.6 billion; CSPC PHARMA received a milestone payment of 25 million USD from AstraZeneca; BASICSEMI's products have increased in price by up to 25%; INSILICO has reached a research and development cooperation with CMS; COUNTRY GARDEN stated that the second half of the year is a critical window period for operations"
datetime: "2026-07-13T01:05:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292419508.md)
  - [en](https://longbridge.com/en/news/292419508.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292419508.md)
---

# 

**Individual Stock News**

1.  Duan Yongping increased his holdings in POP MART (09992.HK), raising his shareholding ratio to 7.65%.
    
2.  China Life (02628.HK): Plans to invest CNY 4.999 billion to jointly establish a semiconductor industry fund with related parties.
    
3.  CHINAHONGQIAO (01378.HK): Net profit in the first half of 2026 is expected to increase by about 39% compared to the same period in 2025, mainly due to the rise in sales prices of the group's aluminum alloy products compared to the same period in 2025.
    
4.  ZHONGLIANG HLDG (02772.HK) reported a cumulative contract sales amount of approximately CNY 3.6 billion and a cumulative contract sales area of about 365,000 square meters in the first half of 2026, with an average contract sales price of approximately CNY 9,900 per square meter.
    
5.  CSPC PHARMA (01093.HK): The company has received a USD 25 million milestone payment for R&D from AstraZeneca on July 10, 2026.
    
6.  BASICSEMI (09971.HK) announced that the price increase for some of its products is expected to be no more than 25%.
    
7.  INSILICO (03696.HK): Has reached a new cooperation agreement with CMS for drug development in the central nervous system field.
    
8.  COUNTRY GARDEN (02007.HK) July management meeting: The second half of the year will be a critical window period for the company's operational transition

### Related Stocks

- [03696.HK](https://longbridge.com/en/quote/03696.HK.md)
- [02628.HK](https://longbridge.com/en/quote/02628.HK.md)
- [01093.HK](https://longbridge.com/en/quote/01093.HK.md)
- [09971.HK](https://longbridge.com/en/quote/09971.HK.md)
- [09992.HK](https://longbridge.com/en/quote/09992.HK.md)
- [601628.CN](https://longbridge.com/en/quote/601628.CN.md)
- [01378.HK](https://longbridge.com/en/quote/01378.HK.md)
- [02772.HK](https://longbridge.com/en/quote/02772.HK.md)
- [02007.HK](https://longbridge.com/en/quote/02007.HK.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [00867.HK](https://longbridge.com/en/quote/00867.HK.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [HPPD.SG](https://longbridge.com/en/quote/HPPD.SG.md)

## Related News & Research

- [20:00 ETInsilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development](https://longbridge.com/en/news/292686183.md)
- [Insilico Medicine Deepens CNS Drug Development Tie-Up With China Medical System](https://longbridge.com/en/news/292416368.md)
- [What Labubu fatigue? Star investor buys bigger stake in Pop Mart](https://longbridge.com/en/news/292458260.md)
- [Pop Mart grants 101,935 share awards under post-IPO scheme, shares close at HK$ 154.9](https://longbridge.com/en/news/292057681.md)
- [CSPC Pharma receives USD 25 million R&D milestone payment from AstraZeneca under collaboration deal](https://longbridge.com/en/news/292333741.md)